Dr. Ray Anton
CDAP: Advancing Understanding of Alcohol and Drug Abuse
Many people believe that addiction to alcohol and other drugs is a moral weakness or lack of willpower. Contrary to this popular belief, scientific research, especially in the last ten years, has shown that addiction is definitely an acquired disease of the brain with genetic and environmental risk factors.
The Center for Drug and Alcohol Programs, known as CDAP, is one of the nation’s premier academic centers for the study and treatment of alcohol and substance abuse. Recognized internationally for its discovery of advanced treatment options, CDAP is utilizing state-of-the-art tools, such as brain imaging, genetics, behavioral pharmacology and medication therapies to provide a greater understanding and better treatments for alcohol and substance abuse. In its 2010 listing, U.S. News and World Report recognized CDAP as the 11th best drug and alcohol abuse academic program in the United States.
The Center for Drug and Alcohol Programs is directed by Dr. Raymond F. Anton and staffed by highly trained substance addiction professionals, including nationally and internationally known researchers and clinicians. Clinical researchers at CDAP participate in the nation’s major clinical trials that are currently ongoing for alcoholism, cocaine, and methamphetamine dependence. We are especially proud of the fact that CDAP houses the Charleston Alcohol Research Center, one of only a few National Institute of Health (NIH)- funded Alcohol Research Centers in the United States.
To learn more about CDAP’s current addiction research and to find out about clinical trial participation and clinical treatment services, please visit our website at www.cdap.musc.edu.
CDAP: An Overview
CDAP's Educational Programs